Putnam Investments to Launch Three Active Exchange Traded Funds


BOSTON–(BUSINESS WIRE)–Putnam Investments announced today that it will launch three transparent and actively managed exchange-traded funds (ETFs) in the coming months, pending the completion of the regulatory filing process.

The new ETFs will each have a distinct investment objective:

  • BDC Putnam Income ETF — Business Development Companies (BDC)
  • Putnam BioRevolutionMT ETFs — Companies operating at the intersection of technology and biology in the “biology revolution”
  • Putnam Emerging Markets Ex-China ETF — Emerging market companies, excluding investments in China and Hong Kong

Building on the company’s launch of its first four active ETFs last year, the new products will leverage Putnam’s existing investment expertise and capabilities and are designed to provide market access to three strategies convincing within an ETF format.

“Putnam continues to strengthen its product line by bringing thoughtful and innovative strategies to market,” said Robert L. Reynolds, President and CEO of Putnam Investments. “We are excited to offer investors and advisors a dynamic set of investment opportunities that will be meaningful additions to Putnam’s growing list of ETFs.”

ETF strategies expected to be launched by Putnam in the coming months include:

  • BDC Putnam Income ETF – Seeks current income by investing primarily in publicly traded BDCs based in the United States and registered with the SEC. BDCs typically invest in, lend capital to, or provide services to private US companies or small capitalization US public companies.
  • Putnam BioRevolutionMT ETFs – Seeks long-term capital appreciation by investing primarily in common stocks of companies of any size, with an emphasis on those that Putnam believes offer the opportunity to benefit from a convergence of technological developments in the industry life sciences. These include technology companies that provide the materials, equipment and knowledge needed for biological innovations, biotechnology or synthetic biology companies, as well as companies that operate in sectors likely to be affected by the biological revolution over time.
  • Putnam Emerging Markets Ex-China ETF – Seeks long-term capital appreciation by investing primarily in common stocks of emerging market companies. Emerging markets include countries in the MSCI Emerging Markets ex China Index or those that Putnam considers to be emerging markets based on an assessment of their level of economic development or the size and experience of their stock markets. . The ETF will exclude companies domiciled or whose shares are listed for trading on a stock exchange in China or Hong Kong.

“We are excited to bring these differentiated strategies to market, to give investors exposure to several important development areas,” said Carlo Forcione, chief product and strategy officer at Putnam Investments.

“The new ETFs are an extension of Putnam’s equity investing capabilities that apply traditional fundamental research, currently employed across a range of products offered by our company in retail mutual funds, ETFs, separately managed accounts , mutual trusts, private funds and non-U.S. funds,” Forcione continued.

Putnam launched its first four active ETFs in May 2021: Putnam Focused Large Cap Growth ETF; Putnam Large Cap Value ETF; Putnam Sustainable Future ETFs; and Putnam Sustainable Leaders ETF.

About Putnam Investments

Founded in 1937, Putnam Investments is a global investment management firm with more than 80 years of investment experience. At the end of April 2022, Putnam had $180 billion in assets under management. Putnam has offices in Boston, London, Munich, Tokyo, Singapore and Sydney. For more information, visit putnam.com.

REMARK: The registration statement relating to these securities has been filed with the SEC but is not yet effective. These securities may not be sold or offers to buy accepted prior to the effective date of the registration statement. This press release does not constitute an offer to sell these securities and does not solicit an offer to buy these securities in any state where the offer or sale is not authorized.


Comments are closed.